Related Experiment Video
Updated: Dec 11, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Modulating immunosuppression in liver transplant patients with COVID-19
Manuel Rodriguez-Peralvarez1,2,3, Magdalena Salcedo3,4, Jordi Colmenero3,5
1Hepatology and Liver Transplantation, Reina Sofia University Hospital, Cordoba, Andalucía, Spain ropeml@hotmail.com.
No abstract available in PubMed .
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Kidney Transplant III: Nursing Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...